Adaptive Biotechnologies Corporation (1HM)
Munich
Closed
Aug 25, 2026
Day's Range
21.9352 wk Range
10.78Overview - 1HM - Adaptive Biotechnologies Corporation
Key Statistics
Valuation
Enterprise Value
2.38B
P/E (Trailing)
‪-56.23‬
PEG Ratio
‪-1.19‬
Price / Sales (TTM)
‪11.13‬
Price / Book
‪27.94‬
EV / EBITDA
‪-130.68‬
Profitability
Profit Margin
‪-20.72%‬
Operating Margin
‪-22.04%‬
Return on Assets
‪-4.11%‬
Return on Equity
‪-38.75%‬
Ownership
Shares Outstanding
159.59M
Float
125.46M
Held by Insiders
‪1.30%‬
Held by Institutions
‪99.25%‬
Price stats
Beta
‪2.08‬
50-Day Avg
‪19.01‬
200-Day Avg
‪14.80‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1HM - Adaptive Biotechnologies Corporation
Peers - 1HM - Adaptive Biotechnologies Corporation
Peer Comparison
Compared with companies in Diagnostics & Research listed on Munich.
- 1HMMunichAdaptive Biotechnologies Corporation3.43BMarket Cap+49.16%52-week change-55.13P/E (Trailing)‪-20.72%‬Profit Margin
- 45EMunichNATERA INC (Common Stock) – ticker 45E27.42BMarket Cap+55.09%52-week change-125.99P/E (Trailing)‪-9.04%‬Profit Margin
- SAB0MunichSonic Healthcare Limited Sponsored ADR6.57BMarket Cap-4.54%52-week change17.60P/E (Trailing)‪5.59%‬Profit Margin
- SH5MunichSotera Health Company4.68BMarket Cap+15.24%52-week change33.06P/E (Trailing)‪13.44%‬Profit Margin
- 0MEMunichTwist Bioscience Corporation3.10BMarket Cap+80.48%52-week change-93.58P/E (Trailing)‪50.72%‬Profit Margin
- BMZMunichBML Inc.734.67MMarket Cap-3.06%52-week change17.73P/E (Trailing)‪5.19%‬Profit Margin
- 7OC0MunichInsight Molecular Diagnostics Inc.90.97MMarket Cap+0.00%52-week change-1.68P/E (Trailing)‪56.67%‬Profit Margin
Profile Summary - 1HM - Adaptive Biotechnologies Corporation
About
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company that develops an immune medicine platform for diagnosing and treating various diseases. The company's core offering is its immunosequencing platform, which uses proprietary chemistry, computational biology, and machine learning to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
